Novo Nordisk said it would follow Lilly and sell the Wegovy obesity shot in a vial



Novo Nordisk said it would follow Lilly and sell the Wegovy obesity shot in a vial



Source link

  • Related Posts

    Siemens raised its full-year profit outlook after beating Q1 forecasts

    Siemens raised its full-year profit outlook after beating Q1 forecasts Source link

    Can AMAT stock maintain momentum?

    Applied Materials (AMAT) will report its fiscal first quarter 2026 earnings on Thursday, February 12th. AMAT shares have rallied significantly, rising around 30% year-to-date (YTD) and over 81% over 12…

    Leave a Reply

    Your email address will not be published. Required fields are marked *